Chronic refractory angina can lead to multiple acute hospital admissions. This can be due to patient and healthcare professional misconceptions regarding the meaning of the chest pain experienced. Symptom control, psychological support and education form an important part of the management of this condition. We describe a case study where intranasal alfentanil provided rapid relief of symptoms preventing repeated hospital admissions.
Chester MRChronic refractory angina: time to sort out a neglected and growing problem . Brit J Cardiol2000; 7(3): 108-111.
2.
Silfast T., Saarnivaara L.Comparison of alfentanil and morphine in the prehospital treatment of patients with acute ischaemic-type chest pain. Eur J Emerg Med2001; 8(4): 275-278.
3.
Streibel HW, Pommerening J., Reiger A.Intranasal fentanyl titration for postoperative pain management in an unselected population. Anaesthesia1993; 48: 753-757.
4.
Schwagmeier R., Boerger N., Meissner W., Walter Striebel H.Pharmacokinetices of Intranasal Alfentanil. J Clin Anaesthesia1995; 7: 109-113.
Davies MJCoronary disease: the pathophysiology of acute coronary syndromes. Heart2000; 83: 361-366.
7.
Moore RK, Groves D., Bateson S., et al. Health related quality of life of patients with refractory angina before and one year after enrolment onto a refractory angina programme. Eur J Pain2005; 9: 305-310.
8.
Roger KG, Moore RK, Groves DG, et al. A brief cognitive behavioural intervention reduces hospital admissions in refractory angina patients. J Pain Symptom Manage2007; 33(3): 310-316.
